Mike, your comments about the NPP in the slide deck really captured my attention. I was curious to hear your view on what would you rank as the primary drivers of the increased demand for your NPP products? Is it the regulatory path and registration of these NPP products? Is it just more streamlined? Is that a key driver? Is it the distribution channel that see these products as an attractive bolt -on. They can put them into their routine applications? Or is it at the grower level where these products like the biostimulants have a yield benefit? How would you rank those as driving the growth in these products?
And one more for you, and that is in the U.S. market, are you seeing any increased interest from either the wholesale or the retail distribution channel to be more interested in, say private label products or potentially more interested in something other than the primary branded products that they have contracts with. Is there increased interest in that? And is that an opportunity for you because you provide the certainty of supply that if they were to just go directly to active generic out of China, there may be less certainty on the supply, particularly with tariffs.